Contact
searchSearch
HMP Global
Login

Advertisement

ADVERTISEMENT

Column

Clinical Pathways GPS
Clinical Pathways Guiding Where and When
09/19/2017
Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor
Clinical pathways most often guide treatment decisions based on a diagnosis, but what about assistance for directing where and when care is most effectively rendered? Improving clinical and financial outcomes...
Clinical pathways most often guide treatment decisions based on a diagnosis, but what about assistance for directing where and when care is most effectively rendered? Improving clinical and financial outcomes...
...
09/19/2017
Journal of Clinical Pathways
Pharma Insights
Are Formulary Exclusion Lists Aligned or Contrary to the Shift to Value-Base Care?
09/19/2017
Andrew Cournoyer, RPh, MBA
Larry Blandford, PharmD—Column Editor
The use of formulary exclusion lists continues to expand, with clear impacts to the perception and use of all related medications. Annual updates to these lists suggest a need for careful evaluation by benefit...
The use of formulary exclusion lists continues to expand, with clear impacts to the perception and use of all related medications. Annual updates to these lists suggest a need for careful evaluation by benefit...
The...
09/19/2017
Journal of Clinical Pathways
Editor's Page
Moving the Clinical Pathways Conversation Forward
09/18/2017
Winston Wong, PharmD, Editor-in-Chief
September brings about many things: the end of summer, the beginning of a new school term, and a march toward the conclusion of another calendar year. For those of us at Journal of Clinical Pathways, September marks...
September brings about many things: the end of summer, the beginning of a new school term, and a march toward the conclusion of another calendar year. For those of us at Journal of Clinical Pathways, September marks...
...
09/18/2017
Journal of Clinical Pathways

Advertisement

Clinical Pathways GPS
Truly Patient-Centered Clinical Pathways
08/16/2017
Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor
Scott Guerin, PhD
For clinical pathways to be most effective, they need to accommodate many external factors impacting patients. These include issues such as the social determinants of health, as well as access to care that can impact...
For clinical pathways to be most effective, they need to accommodate many external factors impacting patients. These include issues such as the social determinants of health, as well as access to care that can impact...
For...
08/16/2017
Journal of Clinical Pathways
Pathways in Focus
Applying First Principles Thinking to Cancer Care Delivery
08/16/2017
Aymen Elfiky, MD, MSc, MBA—Column Editor
A first principle is a basic, foundational, self-evident proposition or assumption that cannot be deduced from any other proposition or assumption. The concept of first principles thinking has been advocated by...
A first principle is a basic, foundational, self-evident proposition or assumption that cannot be deduced from any other proposition or assumption. The concept of first principles thinking has been advocated by...
A...
08/16/2017
Journal of Clinical Pathways
Editor's Page
A Moment in the Spotlight for Clinical Pathways
08/16/2017
Winston Wong, PharmD, Editor-in-Chief
Summer is a time of rest and relaxation, when we recharge our batteries in order to gain the energy needed to propel us through the rest of the year. That’s especially true here at Journal of Clinical Pathways (JCP),...
Summer is a time of rest and relaxation, when we recharge our batteries in order to gain the energy needed to propel us through the rest of the year. That’s especially true here at Journal of Clinical Pathways (JCP),...
Summer...
08/16/2017
Journal of Clinical Pathways

Advertisement

Clinical Pathways GPS
The New FDA and Its Impact on Clinical Pathways
06/14/2017
Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor
Scott Guerin, PhD
President Donald J Trump’s selection of Scott Gottlieb, MD, to lead the Food and Drug Administration (FDA) has ushered in a new direction for the government agency, which is likely to alter the availability and use...
President Donald J Trump’s selection of Scott Gottlieb, MD, to lead the Food and Drug Administration (FDA) has ushered in a new direction for the government agency, which is likely to alter the availability and use...
...
06/14/2017
Journal of Clinical Pathways
Editor's Page
Clinical Pathways: Local, National, and International
06/14/2017
Winston Wong, PharmD, Editor-in-Chief
If you are an oncologist, you are probably picking up this month’s edition of Journal of Clinical Pathways as you return from the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. Given the...
If you are an oncologist, you are probably picking up this month’s edition of Journal of Clinical Pathways as you return from the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. Given the...
If you...
06/14/2017
Journal of Clinical Pathways
Pharma Insights
What Does New Payer Research on Expected Biosimilar Management Mean to Others?
05/12/2017
Larry Blandford, PharmD—Column Editor
Although the biosimilar era has officially launched, only one agent has entered the market as of April 2017. That would be Zarxio1, approved in March 2015 as a biosimilar for the market-leading granulocyte...
Although the biosimilar era has officially launched, only one agent has entered the market as of April 2017. That would be Zarxio1, approved in March 2015 as a biosimilar for the market-leading granulocyte...
...
05/12/2017
Journal of Clinical Pathways

Advertisement

Clinical Pathways GPS
The Next 1361 Days and How They Will Impact Clinical Pathways
05/12/2017
Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor
Over the course of the Trump Administration’s first 100 days, the president and members of Congress have introduced health care reform legislation that aims to profoundly change the ways medicine is practiced—and...
Over the course of the Trump Administration’s first 100 days, the president and members of Congress have introduced health care reform legislation that aims to profoundly change the ways medicine is practiced—and...
Over...
05/12/2017
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

JCP May/June 2024 Issue

Current Issue

June 2024
Volume 10
Issue 3
Current Issue
Issue Archive

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Special Reports

JCP Special Report
Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group
05/20/2022
Winston Wong, PharmD
Gordon Kuntz
Robin T Zon, MD, FACP, FASCO
2021 Care Pathways Working Group
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways...
05/20/2022
Journal of Clinical Pathways
Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma
Special Report
Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma
01/14/2021
01/14/2021
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement

Advertisement

Subscribe

Journal of Clinical Pathways Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use